Received Jul 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (IMOVAX) | SANOFI PASTEUR | UNK | — | OT |
patient who is due to receive their second dose today, on day 7 of the series, but they may not be able to come into the pharmacy with no reported adverse event; Initial information received on 22-Jul-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves an unknown age and unknown gender patient who was due to receive their second dose rabies (HDC) vaccine [Imovax rabies] today, on day 7 of the series, but they may not be able to come into the pharmacy with no reported adverse event. The patient's past medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided. On an unknown date, the patient who was due to receive their second dose of rabies (HDC) vaccine Powder and solvent for suspension for injection (Unknown strength, lot and expiry date) for Immunization on day 7 of the series, but they may not be able to come into the pharmacy with no reported adverse event (routine immunisation schedule not administered) Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.